| Health / Medical Topics |
Selective Estrogen Receptor Degrader ARN-810
An orally available, nonsteroidal selective estrogen receptor degrader (SERD), with potential antineoplastic activity. Upon oral administration, SERD ARN-810 binds to the estrogen receptor and induces a conformational change that results in the degradation of the receptor. This may inhibit the growth and survival of ER-expressing cancer cells. (NCI Thesaurus)
YOU MAY ALSO LIKE
A rare syndrome characterized by deficiency of specific antibodies to polysaccharide antigens while the specific antibodies to protein antigens are normal. …
An error in choosing the individuals or groups to take part in a study. Ideally, the subjects in a study should be…
A family of cell adhesion molecules containing a lectin-like domain, an EGF-like domain, and domains homologous to complement-binding proteins. Selectins mediate…
The description of an identified region within an image.
Human SELE wild-type allele is located within 1q22-q25 and is approximately 11 kb in length. This allele, which encodes E-selectin protein, plays…
This gene plays a role in inflammation by mediating cellular adhesion to vasculature.
